PARIS—The European Union has not yet made any new orders for AstraZeneca vaccines beyond June when their contract ends, European Internal Market Commissioner Thierry Breton said on Sunday. Breton also said he expected that the costs of the EU’s recent order for more doses of Pfizer-BioNTech vaccines would be higher than the earlier versions. The Commission last month launched legal action against AstraZeneca for not respecting its contract for the supply of COVID-19 vaccines and for not having a “reliable” plan to ensure timely deliveries. “We did not renew the order after June. We’ll see what happens,” said Breton, adding that it was “a very good vaccine.” Concerns has risen on potential side-effects of the Anglo-Swedish COVID-19 vaccine. Europe’s medicines regulator said on Friday it is reviewing reports of a rare nerve-degenerating disorder in people who received the shots, a move that comes after it found the vaccine may have …